← SynDRA
LANDIOLOL
SynDRA canonical compound SYN0026725 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRB1 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | cardiac arrythmia |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
- adrenergic receptor antagonist
Drug classes
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-Antagonists
- Anti-Arrhythmia Agents
- Cardiovascular Agents
- Neurotransmitter Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
Cross-references
Synonyms
- rapibloc
- onoact
- ONO 1101
- landiolol hydrochloride
- landiolol HCl
- AOP-200704
- AOP200704
- LDLL-600
- LDLL600
- ONO-1101
- Ono 1101
- landiololum
- RefChem:152225
- DTXCID2080517
- C07AB14
- Rapiblyk
- Landiolol [INN]
- NCGC00182709-01
- NCGC00182709-02
- UNII-62NWQ924LH
- LANDIOLOL [MI]
- Landiolol (USAN/INN)
- Landiolol [USAN:INN]
- LANDIOLOL [USAN]
- LANDIOLOL [WHO-DD]
- SCHEMBL121446
- orb1689917
- GTPL13192
- ONO1101
- CHEBI:135809
- EX-A7978
- WHO 7516
- T5028L
- AKOS015896630
- AT45924
- HY-100607
- NS00069591
- D12410
Look up LANDIOLOL in the interactive SynDRA portal →